Docetaxel Micelles: A New Formulation to Diminish Hypersensitivity Reactions

<b>Background/Objectives</b>: Docetaxel is a potent anti-cancer agent capable of treating various types of cancer. However, it often induces a range of adverse reactions when used with its standard solubilizer, Tween-80, necessitating allergy prophylaxis with dexamethasone prior to admin...

全面介紹

書目詳細資料

發表在:	Pharmaceutics
Main Authors:	Lanlan Xiang, Hao Wang, Jiajie Liu, Yuchen Shen, Yanfen Hu, Wenchen Che, Ran Li, Sisi Yang, Xin Teng
格式:	Article
語言:	英语
出版:	MDPI AG 2025-02-01
主題:	docetaxel nanomicelles allergic reaction
在線閱讀:	https://www.mdpi.com/1999-4923/17/2/184